A citation-based method for searching scientific literature

John Papastergiou, Lena C Quilty, Wilson Li, Thulasi Thiruchselvam, Esha Jain, Peter Gove, Leilany Mandlsohn, Bart van den Bemt, Nedzad Pojskic. Clin Transl Sci 2021
Times Cited: 3







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
Daniel K Hall-Flavin, Joel G Winner, Josiah D Allen, Joseph M Carhart, Brian Proctor, Karen A Snyder, Maureen S Drews, Linda L Eisterhold, Jennifer Geske, David A Mrazek. Pharmacogenet Genomics 2013
121
66

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.
J Winner, J D Allen, C Anthony Altar, A Spahic-Mihajlovic. Transl Psychiatry 2013
88
66


Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists.
Julie-Anne Tanner, Paige E Davies, Nicholas C Voudouris, Anashe Shahmirian, Deanna Herbert, Nicole Braganza, Ana Gugila, Bryan M Dechairo, James L Kennedy. J Psychiatr Res 2018
21
66

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
John F Greden, Sagar V Parikh, Anthony J Rothschild, Michael E Thase, Boadie W Dunlop, Charles DeBattista, Charles R Conway, Brent P Forester, Francis M Mondimore, Richard C Shelton,[...]. J Psychiatr Res 2019
94
66

Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.
Zane Zeier, Linda L Carpenter, Ned H Kalin, Carolyn I Rodriguez, William M McDonald, Alik S Widge, Charles B Nemeroff. Am J Psychiatry 2018
61
66


Pharmacogenetics of psychotropic drug response.
Anil K Malhotra, Greer M Murphy, James L Kennedy. Am J Psychiatry 2004
222
33

Pharmacogenetics and outcome with antipsychotic drugs.
Jennie G Pouget, Tahireh A Shams, Arun K Tiwari, Daniel J Müller. Dialogues Clin Neurosci 2014
37
33

Clinically significant psychotropic drug-drug interactions in the primary care setting.
Brett A English, Marcus Dortch, Larry Ereshefsky, Stanford Jhee. Curr Psychiatry Rep 2012
42
33

Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment.
Silvia Alboni, Silvia Poggini, Stefano Garofalo, Giampaolo Milior, Hassan El Hajj, Cynthia Lecours, Isabelle Girard, Steven Gagnon, Samuel Boisjoly-Villeneuve, Nicoletta Brunello,[...]. Brain Behav Immun 2016
52
33


The potential utility of pharmacogenetic testing in psychiatry.
Kathryn R Gardner, Francis X Brennan, Rachel Scott, Jay Lombard. Psychiatry J 2014
12
33

Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada.
Abdullah Al Maruf, Mikayla Fan, Paul D Arnold, Daniel J Müller, Katherine J Aitchison, Chad A Bousman. Can J Psychiatry 2020
12
33



Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Saiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca-García, Eduard Vieta, José M Olivares,[...]. BMC Psychiatry 2017
88
33

Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings.
Jesen Fagerness, Eileen Fonseca, Gregory P Hess, Rachel Scott, Kathryn R Gardner, Michael Koffler, Maurizio Fava, Roy H Perlis, Francis X Brennan, Jay Lombard. Am J Manag Care 2014
43
33

Cost-effectiveness of combinatorial pharmacogenomic testing for depression from the Canadian public payer perspective.
Julie-Anne Tanner, Paige E Davies, Christopher C Overall, Daniel Grima, Julian Nam, Bryan M Dechairo. Pharmacogenomics 2020
7
33

The genetics of mental illness: implications for practice.
S E Hyman. Bull World Health Organ 2000
31
33

A new population-based measure of the economic burden of mental illness in Canada.
K-L Lim, P Jacobs, A Ohinmaa, D Schopflocher, C S Dewa. Chronic Dis Can 2008
98
33

Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.
Paul Bradley, Michael Shiekh, Vishaal Mehra, Keith Vrbicky, Stacey Layle, Marilyn C Olson, Alejandra Maciel, Ali Cullors, Jorge A Garces, Andrew A Lukowiak. J Psychiatr Res 2018
70
33

CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.
Sahar A Jallaq, Mark Verba, Jeffrey R Strawn, Lisa J Martin, Melissa P DelBello, Laura B Ramsey. J Child Adolesc Psychopharmacol 2021
3
33

Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients.
Chaten D Jessel, Sam Mostafa, Maria Potiriadis, Ian P Everall, Jane M Gunn, Chad A Bousman. Pharmacogenet Genomics 2020
3
33

Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Chad A Bousman, Katarina Arandjelovic, Serafino G Mancuso, Harris A Eyre, Boadie W Dunlop. Pharmacogenomics 2019
70
33


HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.
J A Lieberman, J Yunis, E Egea, R T Canoso, J M Kane, E J Yunis. Arch Gen Psychiatry 1990
190
33

PharmGKB: A worldwide resource for pharmacogenomic information.
Julia M Barbarino, Michelle Whirl-Carrillo, Russ B Altman, Teri E Klein. Wiley Interdiscip Rev Syst Biol Med 2018
84
33

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Peter B Jones, Thomas R E Barnes, Linda Davies, Graham Dunn, Helen Lloyd, Karen P Hayhurst, Robin M Murray, Alison Markwick, Shôn W Lewis. Arch Gen Psychiatry 2006
734
33

Is response to prophylactic lithium a familial trait?
Paul Grof, Anne Duffy, Patrizia Cavazzoni, Eva Grof, Julie Garnham, Marsha MacDougall, Claire O'Donovan, Martin Alda. J Clin Psychiatry 2002
236
33

Worldwide Differences in Regulations of Clozapine Use.
Jimmi Nielsen, Corina Young, Petru Ifteni, Taishiro Kishimoto, Yu-Tao Xiang, Peter F J Schulte, Christoph U Correll, David Taylor. CNS Drugs 2016
81
33

Microdialysis evaluation of clozapine and N-desmethylclozapine pharmacokinetics in rat brain.
Thomas I F H Cremers, Gunnar Flik, Corry Hofland, Robert E Stratford. Drug Metab Dispos 2012
19
33

Triangulation in aetiological epidemiology.
Debbie A Lawlor, Kate Tilling, George Davey Smith. Int J Epidemiol 2016
344
33

Personalized Medicine and the Power of Electronic Health Records.
Noura S Abul-Husn, Eimear E Kenny. Cell 2019
48
33

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.
Elizabeth J Phillips, Chonlaphat Sukasem, Michelle Whirl-Carrillo, Daniel J Müller, Henry M Dunnenberger, Wasun Chantratita, Barry Goldspiel, Yuan-Tsong Chen, Bruce C Carleton, Alfred L George,[...]. Clin Pharmacol Ther 2018
99
33

The "Efficacy-Effectiveness Gap": Historical Background and Current Conceptualization.
Clementine Nordon, Helene Karcher, Rolf H H Groenwold, Mikkel Zöllner Ankarfeldt, Franz Pichler, Helene Chevrou-Severac, Michel Rossignol, Adeline Abbe, Lucien Abenhaim. Value Health 2016
51
33

Pharmacogenetics in Psychiatry: An Update on Clinical Usability.
Ron H N van Schaik, Daniel J Müller, Alessandro Serretti, Magnus Ingelman-Sundberg. Front Pharmacol 2020
15
33

Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.
Meghan J Arwood, Eric A Dietrich, Benjamin Q Duong, D Max Smith, Kelsey Cook, Amanda Elchynski, Eric I Rosenberg, Katherine N Huber, Ying L Nagoshi, Ashleigh Wright,[...]. J Clin Med 2020
13
33

Essential Characteristics of Pharmacogenomics Study Publications.
Caroline F Thorn, Michelle Whirl-Carrillo, Houda Hachad, Julie A Johnson, Ellen M McDonagh, Mark J Ratain, Mary V Relling, Stuart A Scott, Russ B Altman, Teri E Klein. Clin Pharmacol Ther 2019
8
33

The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Theresa A Grebe, George Khushf, Margaret Chen, Dawn Bailey, Leslie Manace Brenman, Marc S Williams, Laurie H Seaver. Genet Med 2020
11
33

The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis.
Robert A McCutcheon, Toby Pillinger, Yuya Mizuno, Adam Montgomery, Haridha Pandian, Luke Vano, Tiago Reis Marques, Oliver D Howes. Mol Psychiatry 2021
15
33


Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
Jacqueline I Goldstein, L Fredrik Jarskog, Chris Hilliard, Ana Alfirevic, Laramie Duncan, Denis Fourches, Hailiang Huang, Monkol Lek, Benjamin M Neale, Stephan Ripke,[...]. Nat Commun 2014
97
33

Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries.
Anthony F Jorm, Scott B Patten, Traolach S Brugha, Ramin Mojtabai. World Psychiatry 2017
172
33

The Curious Neglect of High Functioning After Psychopathology: The Case of Depression.
Jonathan Rottenberg, Andrew R Devendorf, Todd B Kashdan, David J Disabato. Perspect Psychol Sci 2018
14
33

Global pharmacogenomics: where is the research taking us?
Catherine Olivier, Bryn Williams-Jones. Glob Public Health 2014
7
33

Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample.
Carin A T C Lunenburg, Janne P Thirstrup, Jonas Bybjerg-Grauholm, Marie Bækvad-Hansen, David M Hougaard, Merete Nordentoft, Thomas Werge, Anders D Børglum, Ole Mors, Preben B Mortensen,[...]. Transl Psychiatry 2021
2
50

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
Chloe P O'Connell, Andrea N Goldstein-Piekarski, Charles B Nemeroff, Alan F Schatzberg, Charles Debattista, Tania Carrillo-Roa, Elisabeth B Binder, Boadie W Dunlop, W Edward Craighead, Helen S Mayberg,[...]. Am J Psychiatry 2018
19
33

The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention.
Michele Fornaro, Domenico De Berardis, Annalisa Anastasia, Stefano Novello, Andrea Fusco, Carlo Ignazio Cattaneo, Marco Solmi, Francesco Monaco, Nicola Veronese, Yong-Ku Kim,[...]. Psychiatry Res 2018
13
33

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.
Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola,[...]. Ther Adv Drug Saf 2018
60
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.